Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Human Vaccines|December 17, 2009
European Malaria Vaccine Initiative: portfolio and perspectives for the futureEgeruan Babatunde Imoukhuede, Roland Ventura, Nathalie Imbault, et al.Journal of Clinical Research & Bioethics|August 19, 2014
Multimedia Informed Consent Tool for a Low Literacy African Research Population: Development and Pilot-TestingMuhammed Olanrewaju Afolabi, Kalifa Bojang, Umberto D'Alessandro, et al.Vaccine|September 17, 2009
Safety and immunogenicity of GMZ2 - a MSP3-GLURP fusion protein malaria vaccine candidateMeral Esen, Peter G Kremsner, Regina Schleucher, et al.Plos One|May 2, 2015
Health providers' perceptions of clinical trials: lessons from Ghana, Kenya and Burkina FasoVibian Angwenyi, Kwaku-Poku Asante, Abdoulaye Traoré, et al.Vaccine|August 11, 2010
Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, GabonBenjamin Mordmüller, Katja Szywon, Benedikt Greutelaers, et al.Plos One|August 11, 2011
A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African childrenSabine Bélard, Saadou Issifou, Aurore B Hounkpatin, et al.Plos One|December 13, 2018
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and childrenAlfred B Tiono, Issa Nébié, Nicholas Anagnostou, et al.Malaria Journal|September 1, 2016
Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in BandiagaraMahamadou A Thera, Drissa Coulibaly, Abdoulaye K Kone, et al.Pageof 1